InvestorsHub Logo
Followers 466
Posts 26938
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 45

Tuesday, 11/27/2012 8:40:49 AM

Tuesday, November 27, 2012 8:40:49 AM

Post# of 245
3:16AM Regeneron Pharms EYLEA injection approved for the treatment of Wet Age-Related Macular Degeneration in Europe (REGN) 174.39 : Co announces that EYLEA injection has been approved by the European Commission for the treatment of patients with neovascular age-related macular degeneration. EYLEA was approved for the treatment of neovascular AMD in the United States in November 2011 and in Japan, Australia, Switzerland, and other countries this year. Bayer HealthCare (BAYRY) plans to launch EYLEA in these countries later in 2012 and into 2013. In the United States, EYLEA was also approved for the treatment of Macular Edema following Central Retinal Vein Occlusion in September 2012

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent REGN News